Insulin glargine and lixisenatide and Neomycin and Fluocinolone
Determining the interaction of Insulin glargine and lixisenatide and Neomycin and Fluocinolone and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: fluocinolone / neomycin topical
Brand name: Neo-Synalar
Synonyms: Fluocinolone and neomycin topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Neomycin and Polymyxin B
- Insulin glargine and lixisenatide-Neomycin and Polymyxin B Irrigation
- Insulin glargine and lixisenatide-Neomycin and Polymyxin B Sulfates
- Insulin glargine and lixisenatide-Neomycin and polymyxin b Topical
- Insulin glargine and lixisenatide-Neomycin Oral Solution
- Insulin glargine and lixisenatide-Neomycin Sulfate
- Neomycin and Fluocinolone-Insulin glargine and lixisenatide Subcutaneous
- Neomycin and Fluocinolone-Insulin glargine, recombinant Subcutaneous
- Neomycin and Fluocinolone-Insulin glulisine
- Neomycin and Fluocinolone-Insulin Glulisine (Cartridges and Pens)
- Neomycin and Fluocinolone-Insulin Glulisine (Vials)
- Neomycin and Fluocinolone-Insulin glulisine Subcutaneous